Editor’s word: LimeLight, the most recent addition to WRAL TechWire’s rising lineup, gives methods for corporations and people to convey extra consideration to their efforts.
DURHAM – Parexel, a number one supplier of options to speed up the event and supply of modern therapies to enhance world well being, from medical by means of commercialization, at this time introduced the appointment of Clare Grace, Ph.D., as the corporate’s first Chief Affected person Officer. The appointment displays the function of the affected person as central to the corporate’s mission of protecting sufferers on the coronary heart of all medical trial exercise.
The appointment of a Chief Affected person Officer is a primary for a top-tier CRO, additional demonstrating Parexel’s dedication to raise the affected person perspective in order that their distinctive wants can be utilized to form the conduct of future medical research.
“Sufferers are on the coronary heart of all the things we do,” mentioned Sy Pretorius, MD, Chief Medical and Scientific Officer at Parexel. “Clare’s confirmed monitor report of delivering modern affected person and web site engagement packages make her the proper candidate to steer our patient-focused mission. We’re happy to welcome her to Parexel as we additional evolve our help for sufferers and investigative websites worldwide.”
“I’m thrilled to affix Parexel and to proceed to champion the corporate’s affected person focus to in the end enhance medical trials and speed up the supply of recent therapies for sufferers around the globe,” mentioned Dr. Grace. “I sit up for working intently with our websites and expertise companions to enhance the affected person expertise and to additional infuse the affected person perspective throughout all research and additional improve our skill to ship modern medical trial options that meet our prospects’ wants.”
With greater than 20 years of expertise within the CRO and biopharmaceutical industries, Dr. Grace was acknowledged in 2018 by PharmaVoice as one of many prime 100 most inspirational leaders within the pharmaceutical trade. She earned a doctorate in Molecular Oncology from the College of Manchester Institute of Science and Know-how and a bachelor’s diploma in utilized biochemistry from Liverpool John Moores College, each in England. Dr. Grace is lively in a number of world and national-level advisory teams, together with the Society for Medical Analysis Websites (SCRS) and the SCRS Management Council.
As Chief Affected person Officer for Parexel, Dr. Grace will lead world affected person advocacy and web site efforts, together with affected person engagement methods and efforts to reinforce medical trial range in addition to new, modern approaches to assist groups and prospects work extra successfully with investigative websites. Most lately she served as Vice President, Website & Affected person Entry at Syneos Well being, previously INC Analysis, the place she oversaw all departments answerable for affected person engagement, feasibility, web site identification, strategic web site relations and investigator funds. Her expertise additionally contains senior-level affected person and site-focused management roles with PPD, Astra Zeneca and Antisoma.